BAY 55-9837 Chemical Properties

storage temp. 

Store at -20°C

form 

Powder

color 

White to off-white

Water Solubility 

Soluble to 2 mg/ml in water

Sequence

His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Val-Ala-Ala-Lys-Lys-Tyr-Leu-Gln-Ser-Ile-Lys-Asn-Lys-Arg-Tyr-NH2

BAY 55-9837 Usage And Synthesis

Uses

Bay 55-9837 is a potent and highly selective agonist of VPAC2, with a Kd of 0.65 nM. Bay 55-9837 may be a useful therapy for the research of type 2 diabetes[1].

storage

Store at -20°C

References

[1] Tsutsumi M, et, al. A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes. Diabetes. 2002 May; 51(5): 1453-60. DOI:10.2337/diabetes.51.5.1453

BAY 55-9837(463930-25-8)Related Product Information

• LEU-ENKEPHALIN AMIDE
• Met-enkephalinamide
• H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH
• PACAP (1-27), human, ovine, rat (TFA)
• H-ALA-ARG-LEU-ASP-VAL-ALA-SER-GLU-PHE-ARG-LYS-LYS-TRP-ASN-LYS-TRP-ALA-LEU-SER-ARG-NH2
• MM 54
• CYT-1010
• BAY 55-9837